Entering text into the input field will update the search result below

Aratana Therapeutics' (PETX) CEO Steven St. Peter on Q3 2017 Results - Earnings Call Transcript

SA Transcripts profile picture
SA Transcripts

Aratana Therapeutics (NASDAQ:PETX) Q3 2017 Earnings Conference Call November 3, 2017 8:30 AM ET


Rachel Reiff - Corporate Communications

Steven St. Peter - President and CEO

Craig Tooman - CFO


Tim Lugo - William Blair

Bruce Jackson - Lake Street Capital Markets

Swayampakula Ramakanth - H.C. Wainwright

David Gu - Jefferies


Good morning and welcome to the Aratana Therapeutics Third Quarter 2017 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded.

I would now like to turn the conference over to Rachel Reiff, Corporate Communications. Please go ahead.

Rachel Reiff

Thanks and good morning, this is Rachel Reiff, Corporate Communications for Aratana Therapeutics. In a few moments, Dr. Steven St. Peter, President and CEO of Aratana Therapeutics will make some opening comments; and Craig Tooman, our Chief Financial Officer, will then review the third quarter 2017 financial results and then we will open it up for Q&A.

Before we begin, I’d like to let you know that we will be making some forward-looking statements today. These statements involve uncertainties and risks and therefore should not be relied upon as predictions of future events. Actual events and circumstances, which may be beyond our control, may differ from today’s forward-looking statements, including, but not limited to, as a result of the risks, uncertainties and other important factors set forth in our filings with the SEC. Steven?

Steven St. Peter

Thank you Rachel. Good morning, this is Steven St. Peter, President and CEO of Aratana Therapeutics. I'm pleased to review the highlights from third quarter of 2017 and the weeks thereafter. Let me begin by saying that Aratana is very excited to be in the market with our third FDA regulated pet

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.